Invited Speaker
37th TROG Cancer Research Annual Scientific Meeting 2025
Days
Tuesday, 18th March
Wednesday, 19th March
Thursday, 20th March
Friday, 21st March
Search
Speakers
NRG-GU013/ TD24.09: The Phase 3 ‘HIGH-FIVE’ trial. Five fraction radiation for high-risk prostate cancer (Cat B; In development)
(#6)
Wee Loon Ong
1
,
Therese Kang
1
Alfred Health Radiation Oncology, Brunswick, VIC, Australia
Content is not available at the time of publishing.